Underreporting of suspected adverse drug reactions to newly marketed ('black triangle') drugs in general practice: Observational study

British Medical Journal

Volumn 317, Issue 7151, 1998, Pages 119-120

  Martin, R M ^a   Kapoor, K V ^a   Wilton, L V ^a   Mann, R D ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; FAMCICLOVIR; FLUINDOSTATIN; GABAPENTIN; LANSOPRAZOLE; LOSARTAN; NEW DRUG; RISPERIDONE; TRAMADOL; VENLAFAXINE; ZOLPIDEM;

ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GENERAL PRACTICE; HUMAN; PRIORITY JOURNAL; SIDE EFFECT; UNITED KINGDOM;

EID: 0032508249     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7151.119     Document Type: Article

References (5)